Elena Barbieri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elena Barbieri has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Anna Myriam Perrone
Department of Medical and Surgical Sciences (DIMEC) University of Bologna Bologna Italy
1 shared publication Claudio Zamagni
SSD Oncologia Medica, AOU di Bologna, Policlinico S. Orsola-Malpighi, 40138 Bologna, Italy
1 shared publication- Daniela Turchetti
Medical Genetics Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
1 shared publication Donatella Santini
UO Anatomia Patologica, AOU di Bologna, Policlinico S. Orsola-Malpighi, 40138 Bologna, Italy
1 shared publication- Flora Guerra
Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Via Provinciale Lecce-Monteroni n.165, 73100 Lecce, Italy
1 shared publication - Giulia Girolimetti
Department of Experimental Medicine (DiMeS), University of Salento, Via Provinciale Lecce-Monteroni 165, 73100 Lecce, Italy
1 shared publication
Latest Publications
- Open Access
- 1 January 2014
- Published by Wiley in BioMed Research International
- Vol. 2014, 1-11
BRCA-Associated Ovarian Cancer: From Molecular Genetics to Risk Management
Ovarian cancer (OC) mostly arises sporadically, but a fraction of cases are associated with mutations in BRCA1 and BRCA2 genes. The presence of a BRCA mutation in OC patients has been suggested as a prognostic and predictive factor. In addition, the identification of asymptomatic carriers of such mutations offers an unprecedented opportunity for OC prevention. This review is aimed at exploring the current knowledge on epidemiological and molecular aspects of BRCA-associated OC predisposition, on pathology and clinical behavior of OC occurring in BRCA mutation carriers, and on the available options for managing asymptomatic carriers.
- 1 January 2014
- Published by Wiley in BioMed Research International
- Vol. 2014, 1-11
Open AccessBRCA-Associated Ovarian Cancer: From Molecular Genetics to Risk Management
Ovarian cancer (OC) mostly arises sporadically, but a fraction of cases are associated with mutations in BRCA1 and BRCA2 genes. The presence of a BRCA mutation in OC patients has been suggested as a prognostic and predictive factor. In addition, the identification of asymptomatic carriers of such mutations offers an unprecedented opportunity for OC prevention. This review is aimed at exploring the current knowledge on epidemiological and molecular aspects of BRCA-associated OC predisposition, on pathology and clinical behavior of OC occurring in BRCA mutation carriers, and on the available options for managing asymptomatic carriers.